The Procter & Gamble Company

Informe acción NYSE:PG

Capitalización de mercado: US$332.3b

Procter & Gamble Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Procter & Gamble de 3.8% y 3.1% por año respectivamente. Se prevé que el BPA crezca en un 4.6% al año. Se espera que la rentabilidad financiera sea de 34.3% en 3 años.

Información clave

3.8%

Tasa de crecimiento de los beneficios

4.57%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Household Products4.6%
Tasa de crecimiento de los ingresos3.1%
Rentabilidad financiera futura34.32%
Cobertura de analistas

Good

Última actualización14 May 2026

Actualizaciones recientes sobre el crecimiento futuro

Artículo de análisis • Aug 06

The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...

Recent updates

Actualización de narrativa • May 04

PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns

Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Seeking Alpha • Apr 25

Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold

Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Nueva narrativa • Apr 24

Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples

Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.
Actualización de narrativa • Apr 20

PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns

Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).
Actualización de narrativa • Apr 05

PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns

Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).
Actualización de narrativa • Mar 22

PG: Product Refresh And Buybacks Will Support Future Earnings Resilience

Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.
Actualización de narrativa • Mar 08

PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook

Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.
Actualización de narrativa • Feb 21

PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook

Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.
Actualización de narrativa • Feb 07

PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook

Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Actualización de narrativa • Jan 25

Q2 2026 Update

Update narrative with most recent financial statements.
Actualización de narrativa • Jan 23

PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook

Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).
Actualización de narrativa • Jan 07

PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook

Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).
Actualización de narrativa • Dec 16

PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook

Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.
Actualización de narrativa • Dec 02

PG: Share Repurchase And New Collections Will Drive Continued Momentum

Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.
Actualización de narrativa • Nov 18

PG: Share Buybacks And New Guidance Will Support Steady Uptrend

Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.
Actualización de narrativa • Nov 03

PG: Share Buyback And Product Rollout Will Drive Long-Term Upside

Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.
Actualización de narrativa • Oct 20

Rising Consumer Confidence And Product Investment Will Expand US Markets

Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.
Artículo de análisis • Aug 06

The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...
User avatar
Nueva narrativa • Jul 21

Procter & Gamble: A Dividend Giant Facing Slowing Growth

United States: 48.21%1-Year Revenue Growth = 4.65%
Artículo de análisis • Jun 27

The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...
Seeking Alpha • Apr 22

Procter & Gamble: Hold This Stodgy Stalwart

Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking Alpha

Previsiones de crecimiento de beneficios e ingresos

NYSE:PG - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
6/30/202892,67917,99816,73522,40615
6/30/202789,54517,13415,45820,77921
6/30/202687,08216,46214,76118,86321
3/31/202686,71716,32315,02819,410N/A
12/31/202585,25916,16214,84819,070N/A
9/30/202584,93316,47314,94318,923N/A
6/30/202584,28415,68314,04417,817N/A
3/31/202583,92715,20615,02618,586N/A
12/31/202484,34615,19215,47118,969N/A
9/30/202483,90514,03115,85419,244N/A
6/30/202484,03914,59516,52419,846N/A
3/31/202484,06014,84516,16019,433N/A
12/31/202383,93314,48816,00219,208N/A
9/30/202383,26514,95414,58517,682N/A
6/30/202382,00614,37113,78616,848N/A
3/31/202380,96814,03812,20015,220N/A
12/31/202280,28113,99711,56614,603N/A
9/30/202280,46114,28713,19516,150N/A
6/30/202280,18714,46113,56716,723N/A
3/31/202279,61814,31413,95317,131N/A
12/31/202178,34614,23114,88517,972N/A
9/30/202177,13813,86615,24718,275N/A
6/30/202176,11814,03515,58418,371N/A
3/31/202174,87013,93316,32519,056N/A
12/31/202073,97513,58216,22719,033N/A
9/30/202072,47013,44715,12917,973N/A
6/30/202070,95012,76414,33017,403N/A
3/31/202070,3464,72513,51916,748N/A
12/31/201969,5944,553N/A16,201N/A
9/30/201968,7924,029N/A15,844N/A
6/30/201967,6843,634N/A15,242N/A
3/31/201967,09310,767N/A15,290N/A
12/31/201866,91210,523N/A15,126N/A
9/30/201866,8699,827N/A14,803N/A
6/30/201866,8329,485N/A14,867N/A
3/31/201866,4089,813N/A14,356N/A
12/31/201765,7329,838N/A14,043N/A
9/30/201765,1939,884N/A13,359N/A
6/30/201765,0589,862N/A12,753N/A
3/31/201765,0819,648N/A13,204N/A
12/31/201665,2319,427N/A13,442N/A
9/30/201665,2909,767N/A14,922N/A
6/30/201665,2999,676N/A15,435N/A
3/31/201665,7508,147N/A15,284N/A
12/31/201566,9258,213N/A15,558N/A
9/30/201568,5057,972N/A14,513N/A
6/30/201570,7497,920N/A14,608N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (3.8% al año) de PG es superior a la tasa de ahorro (3.5%).

Beneficios vs. Mercado: Se prevé que los beneficios (3.8% al año) de PG crezcan menos que el mercado US (16.8% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de PG crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (3.1% al año) de PG crezcan más despacio que el mercado de US (11.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.1% al año) de PG crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de PG sea alta dentro de 3 años (34.3%)

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/15 14:23
Precio de las acciones al final del día2026/05/15 00:00
Beneficios2026/03/31
Ingresos anuales2025/06/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

The Procter & Gamble Company está cubierta por 43 analistas. 21 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Christopher GrajaArgus Research Company
Lauren LiebermanBarclays
Lauren LiebermanBarclays